Aptamer‐Targeted PrPC Drives Colorectal Cancer Metastasis via a LYN‐STAT3 Complex and Enables Liquid Biopsy Detection
Authors:
Open Access
- 19 May 2026
- journal article
- Published by Wiley in Advanced Science
- Vol. 13 (45) , e75758
Abstract
Colorectal cancer (CRC) poses a significant global health challenge, highlighting the need for better diagnostic tools and molecular targets. Compared to traditional antibodies, aptamers, which are single‐stranded oligonucleotides with high affinity and low immunogenicity, offer an ideal platform for discovering novel biomarkers. Based on this approach, we used the Cell‐SELEX strategy to develop a high‐affinity aptamer‐based probe, WHY‐3E, which successfully identified the cellular prion protein (PrPC) as a key molecular target. We observed that PrPC was significantly upregulated in CRC tissues, strongly correlating with unfavorable clinical outcomes. Functionally, PrPC promotes malignant phenotypes, including migration and invasion, by regulating MSN. Mechanistically, we revealed that PrPC physically translocates from the cell surface to the cytoplasm via endocytosis. Once internalized, it interacts with the STAT3‐NTD and LYN‐SH domains, facilitating the ternary complex formation that enhances LYN‐mediated STAT3 phosphorylation, ultimately increasing MSN transcriptional activity. Moreover, the deubiquitinase USP18 stabilizes PrPC by removing its Lys48‐linked ubiquitin chains, ensuring the continuous activation of this oncogenic axis. Notably, the WHY‐3E aptamer achieved 90.6% sensitivity and 89.0% specificity in detecting PrPC‐positive circulating exosomes in patient cohorts. These findings deepen the mechanistic understanding of CRC progression and offer novel strategic avenues for PrPC‐targeted aptamer applications in non‐invasive diagnostics.Keywords
Funding Information
- National Natural Science Foundation of China (U23A20482)
- National Natural Science Foundation of China (62276084)
- National Natural Science Foundation of China (22274139)
- National Natural Science Foundation of China (22293030)
- National Natural Science Foundation of China (22293031)
- National Natural Science Foundation of China (82002506)
This publication has 53 references indexed in Scilit:
- Metastatic colorectal cancer: mechanisms and emerging therapeuticsTrends in Pharmacological Sciences, 2023
- Recent advances in metabolism and toxicity of tyrosine kinase inhibitorsPharmacology & Therapeutics, 2022
- STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy responsePharmacological Research, 2022
- Translation of aptamers toward clinical diagnosis and commercializationBiosensors and Bioelectronics, 2022
- The role of the tyrosine kinase Lyn in allergy and cancerMolecular Immunology, 2021
- Functions of the Prion Protein2017
- Aptamer selection by direct microfluidic recovery and surface plasmon resonance evaluationBiosensors and Bioelectronics, 2016
- The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence – A systematic reviewInternational Journal of Surgery, 2016
- Moesin regulates the motility of oral cancer cells via MT1-MMP and E-cadherin/p120-catenin adhesion complexOral Oncology, 2015
- Conservative secondary structure motif of streptavidin-binding aptamers generated by different laboratoriesBioorganic & Medicinal Chemistry, 2010